(Q42982877)

12 November 2017

Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

Toyoda H

1

1 reference

12 November 2017

Kumada T

2

1 reference

12 November 2017

Nakano S

3

1 reference

12 November 2017

Takeda I

4

1 reference

12 November 2017

Sugiyama K

5

1 reference

12 November 2017

Osada T

6

1 reference

12 November 2017

Kiriyama S

7

1 reference

12 November 2017

Sone Y

8

1 reference

12 November 2017

Kinoshita M

9

1 reference

12 November 2017

Hadama T

10

1 reference

12 November 2017

1 January 1997

1 reference

12 November 2017

Journal of Hepatology

1 reference

12 November 2017

26

1 reference

12 November 2017

1

1 reference

12 November 2017

6-13

1 reference

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Other approaches to the treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Detection of hepatitis C viral RNA by the polymerase chain reaction in serum of patients with post-transfusion non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Retreatment with recombinant interferon-alpha in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Retreatment of chronic hepatitis C with interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Treatment of chronic type C hepatitis with alpha interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Recombinant alpha-interferon treatment of non-A, and non-B (type C) hepatitis: review of studies and recommendations for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: no correlation of outcome to presence of hepatitis C virus antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Treatment of chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Quantitative HCV RNA and effect of interferon therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

HCV genotypes in chronic hepatitis C and response to interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

F-SSCP: fluorescence-based polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Therapy of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Rapid evolution of RNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

RNA virus populations as quasispecies.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Structure and organization of the hepatitis C virus genome isolated from human carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Genetic organization and diversity of the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

cDNA clones of Japanese hepatitis C virus genomes derived from a single patient show sequence heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Heterogeneity within the nonstructural protein 5-encoding region of hepatitis C viruses from a single patient

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Differential pattern of sequence heterogeneity in the hepatitis C virus E1 and E2/NS1 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

Pretreatment viral load and response to prolonged interferon-alpha course for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980002-5

7 January 2021

10.1016/S0168-8278(97)80002-5

Identifiers

DOI

1 reference

12 November 2017

1 reference